Key statistics
On Thursday, Resmed Inc (RMD:NYQ) closed at 259.05, -11.83% below its 52-week high of 293.81, set on Aug 22, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 256.05 |
|---|---|
| High | 258.20 |
| Low | 250.97 |
| Bid | -- |
| Offer | -- |
| Previous close | 259.05 |
| Average volume | 900.82k |
|---|---|
| Shares outstanding | 145.68m |
| Free float | 144.94m |
| P/E (TTM) | 25.61 |
| Market cap | 37.74bn USD |
| EPS (TTM) | 10.12 USD |
| Annual div (ADY) | 2.40 USD |
|---|---|
| Annual div yield (ADY) | 0.93% |
| Div ex-date | Feb 12 2026 |
| Div pay-date | Mar 19 2026 |
Data delayed at least 15 minutes, as of Mar 05 2026 21:00 GMT.
More ▼
- Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
- Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
- Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
- Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
- Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
- Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
- Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
- Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
- Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
- Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
More ▼
